Christian Lewis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christian Lewis has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Sarah E. Gullbrand
Department of Orthopaedic Surgery University of Pennsylvania Philadelphia Pennsylvania USA
3 shared publications Brandon Lawrence
Department of Orthopaedic Surgery University of Utah Salt Lake City Utah USA
2 shared publications- Hunter Levis
Department of Biomedical Engineering, University of Utah, Salt Lake City, UT, United States
2 shared publications - Jacob Tyler Polaski
Huntsman Cancer Institute University of Utah Salt Lake City Utah USA
2 shared publications - James Christopher Iatridis
Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
2 shared publications Josh Mizels
Department of Orthopaedic Surgery University of Utah Salt Lake City Utah USA
2 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Wiley in Aging Cell
- Vol. 25 (10) , e70754
ZNF865 (BLST) a Novel Regulator of DNA Damage and Cell Senescence in Back Pain
Senescence has been shown to contribute to the progression of aging‐related diseases including degenerative disc disease (DDD). However, the mechanisms regulating senescence in the intervertebral disc (IVD) and other tissues/diseases remain poorly understood. Recently, ZNF865 (BLST) was identified as a previously uncharacterized zinc finger protein that regulates a wide array of genes related to protein processing, cell senescence, and DNA damage repair. Here, we show that ZNF865 expression decreases with age and pathology in human and mouse IVD samples. Utilizing CRISPR‐guided gene modulation, we show that ZNF865 is necessary for healthy cell function and is a critical protein in regulating senescence and DNA damage in IVD cells, with implications for a wide range of tissues and organs. We also demonstrate that downregulation of ZNF865 induces senescence in asymptomatic human nucleus pulposus (NP) cells. Conversely, restoration in degenerative NP cells mitigates senescence, SASP expression, and DNA damage, enhances ECM anabolism, and restores chromatin accessibility and gene expression to a healthy state. In vivo, CRISPRi of ZNF865 induces disc degeneration and painful behaviors. Collectively, our findings establish ZNF865 as a novel regulator of genome stability and a potential therapeutic target for mediating senescence/DNA damage in aging related diseases.
- 9 October 2026
- Published by Wiley in Aging Cell
- Vol. 25 (10) , e70754
Open AccessZNF865 (BLST) a Novel Regulator of DNA Damage and Cell Senescence in Back Pain
Senescence has been shown to contribute to the progression of aging‐related diseases including degenerative disc disease (DDD). However, the mechanisms regulating senescence in the intervertebral disc (IVD) and other tissues/diseases remain poorly understood. Recently, ZNF865 (BLST) was identified as a previously uncharacterized zinc finger protein that regulates a wide array of genes related to protein processing, cell senescence, and DNA damage repair. Here, we show that ZNF865 expression decreases with age and pathology in human and mouse IVD samples. Utilizing CRISPR‐guided gene modulation, we show that ZNF865 is necessary for healthy cell function and is a critical protein in regulating senescence and DNA damage in IVD cells, with implications for a wide range of tissues and organs. We also demonstrate that downregulation of ZNF865 induces senescence in asymptomatic human nucleus pulposus (NP) cells. Conversely, restoration in degenerative NP cells mitigates senescence, SASP expression, and DNA damage, enhances ECM anabolism, and restores chromatin accessibility and gene expression to a healthy state. In vivo, CRISPRi of ZNF865 induces disc degeneration and painful behaviors. Collectively, our findings establish ZNF865 as a novel regulator of genome stability and a potential therapeutic target for mediating senescence/DNA damage in aging related diseases.
- Open Access
ZNF865 (BLST) Regulates Back Pain via Cell Senescence and DNA Damage Mechanisms
Senescence has been shown to contribute to the progression of aging related diseases, yet its regulation in the intervertebral disc (IVD) remains poorly understood. Recently, ZNF865 (BLST) was identified as a previously uncharacterized zinc finger protein, that regulates a wide array of genes related to protein processing, cell senescence and DNA damage repair. Here, we show that ZNF865 expression decreases with age and pathology in human and mouse IVD samples. Depletion of ZNF865 induces senescence, SASP expression and DNA damage in both human and rat healthy NP cells. Conversely, restoration in degenerative NP cells mitigates senescence, SASP expression and DNA damage, enhances ECM anabolism, and restores chromatin accessibility and gene expression to a healthy state. In vivo, CRISPRi of ZNF865 induces disc degeneration and painful behaviors. Collectively, our findings establish ZNF865 as a regulator of genome stability and a potential therapeutic target for mediating senescence/DNA damage in aging related diseases. One Sentence Summary: ZNF865 is a novel modulator of genome stability and senescence and regulates pain outcomes in the intervertebral disc via reversible senescence and DNA damage pathways.
Open AccessZNF865 (BLST) Regulates Back Pain via Cell Senescence and DNA Damage Mechanisms
Senescence has been shown to contribute to the progression of aging related diseases, yet its regulation in the intervertebral disc (IVD) remains poorly understood. Recently, ZNF865 (BLST) was identified as a previously uncharacterized zinc finger protein, that regulates a wide array of genes related to protein processing, cell senescence and DNA damage repair. Here, we show that ZNF865 expression decreases with age and pathology in human and mouse IVD samples. Depletion of ZNF865 induces senescence, SASP expression and DNA damage in both human and rat healthy NP cells. Conversely, restoration in degenerative NP cells mitigates senescence, SASP expression and DNA damage, enhances ECM anabolism, and restores chromatin accessibility and gene expression to a healthy state. In vivo, CRISPRi of ZNF865 induces disc degeneration and painful behaviors. Collectively, our findings establish ZNF865 as a regulator of genome stability and a potential therapeutic target for mediating senescence/DNA damage in aging related diseases. One Sentence Summary: ZNF865 is a novel modulator of genome stability and senescence and regulates pain outcomes in the intervertebral disc via reversible senescence and DNA damage pathways.
- 8 November 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 191, 276-291
Targeted CRISPR regulation of ZNF865 enhances stem cell cartilage deposition, tissue maturation rates, and mechanical properties in engineered intervertebral discs
- 8 November 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 191, 276-291
Targeted CRISPR regulation of ZNF865 enhances stem cell cartilage deposition, tissue maturation rates, and mechanical properties in engineered intervertebral discs